Recent Head and Neck Cancer News

Nimotuzumab in Combination With Concurrent Radiotherapy and Cisplatin Is Active in Locally Advanced SCCHN

(July 19, 2018)

Nimotuzumab in combination with concurrent radiotherapy and cisplatin provides significant clinical benefits in patients with locally advanced squamous cell carcinoma of the head and neck (SCCHN). About... Continue Reading


University of Colorado Study Suggests new Combination Treatment for Head and Neck Cancer

(June 14, 2018)

The five-year survival rate for locally-advanced head and neck cancer is only 46 percent, even with treatments including surgery, radiation, chemotherapy and/or genetically targeted treatments such as... Continue Reading


Managing Side Effects From EGFR Inhibitors

(April 10, 2018)

CancerConnect News: Epidermal Growth Factor Receptor (EGFR) inhibitor drugs are a type of precision cancer medicine commonly used to treat lung, colon, head and neck and other cancers that over express... Continue Reading


Spring into Action For Oral, Head, and Neck Cancer Awareness Week!

(April 3, 2018)

CancerConnect News: As the month of April brings head and neck cancer into focus, it’s time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention,... Continue Reading


Guidelines for Human Papilloma Virus Testing in Head and Neck Carcinomas

(February 6, 2018)

CancerConnect News:  The Centers for Disease Control and Prevention estimates that in the United States, there are more than 16,000 individuals diagnosed with Human Papilloma Virus (HPV)-positive OroPharyngeal... Continue Reading


Depressive Symptoms Linked to Shorter Survival in Patients with Head and Neck Cancer

(January 31, 2018)

CancerConnect News:  In a study of patients with head and neck cancer, even mild depressive symptoms were associated with poorer overall survival according to a team of doctors from the University of... Continue Reading


Head and Neck Cancer Patients at Risk of Cognitive Problems Following Treatment

(January 8, 2018)

CancerConnect News: Patients who survive head and neck cancer may be more likely to experience declines in mental function according to the results of a recent study. The findings are drawn from cognitive... Continue Reading